The OATV-backed user interface software provider increased its valuation fivefold to $10bn in a round co-led by Morgan Stanley and Durable Capital Partners.

Citi, Cuna Mutual Group and New York Life have contributed to a series D round for the financial advice provider at a valuation topping $1bn.

GV, Latacora and Salesforce Ventures helped the app development technology provider close its latest round, which will support hiring and research and development.

The data warehousing software developer has received cash from investors including GV, Telstra Ventures, M12 and National Grid Ventures to bring its total funding to $195m.

DNA Capital has returned to lead a $59.5m round for the Qualcomm Ventures-backed digital prescription startup.

BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.

Novo and Orlando Health helped the haemodialysis technology provider increase its overall funding to $350m since it was spun off by IMI.

Harvard-aligned venture capital firm Xfund has reinvested in ImmuneID, which is developing precision immunology therapies based on Harvard University and Johns Hopkins University research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MIT mRNA therapeutics spinout Strand has secured series A funding from BeiGene, Redmile Group, Camford Capital, Playground Global and Anri.